Source: http://cme-cvs.eu/speakers/karlis-trusinskis-md-lv/
Timestamp: 2019-04-20 16:36:29+00:00

Document:
Prognostic value of tryptophan load test followed by serum kynurenine determination. Its comparison with pyridoxal-5-phosphate, kynurenine, homocysteine and neopterin amounts. Rudzite V, Fuchs D, Kalnins U, Jurika E, Silava A, Erglis A, Trusinskis K, Jegere S.
Advances in experimental medicine and biology; 2003;527:307–15.
Immune activation and degradation of tryptophan in coronary heart disease.
Wirleitner B, Rudzite V, Neurauter G, Murr C, Kalnins U, Erglis A, Trusinskis K, Fuchs D European journal of clinical investigation; 2003 Jul;33(7­):550–4.
Homocysteine, pyridoxal-5-phosphate and neopterin in patients with coronary heart disease.
V. Rudzite, A. Silava, U. Kalnins, A. Erglis, K. Trusinskis, M. Jaeger, D. Fuchs.
Significance of the determination of serum neopterin and homocysteine concentrations as well as pyridoxal-5-phosphate deficiency in patients with coronary heart disease.
Comparing the sensitivity pf pyridoxal-5-phospate, homocysteine and neopterin in coronary heart disease.
V. Rudzite, A. Jurika, U. Kalnins, A. Erglis, K. Trusinskis, S. Jegere, B. Frick, D. Fuchs.
Changes in lipid metabolism in patients with coronary heart disease.
V. Rudzite, E. Jurika, U. Kalnins, A. Erglis, K. Trusinskis, S. Jegere.
Proceedings of the Latvian Academy of Sciences, Section B 2002; 56(3): 109–113.
Homocysteine, B vitamins and immune activation in coronary heart disease.
B. Frick, V. Rudzite, K. Schröcksnadel, U. Kalnins, A. Erglis, K. Trusinskis, D. Fuchs.
Serum concentration of C-reactive protein, neopterin and phospholipids in patients with coronary artery disease.
V. Rudzite, E. Jurika, D. Fuchs, B. Wirteiter, U. Kalnins, A. Erglis, K. Trusinskis.
Usefulness of neopterin, C-reactive protein, homocysteine, pyridoxal-5-phosphate, and phospholipid determination in coronary artery disease.
V. Rudzite, E. Jurika, K. Schroecksnadel, U. Kalnins, A. Erglis, K. Trusinskis, D. Fuchs.
Inflammation, homocysteine, pyridoxal-5-phosphate, and lipids in patients with coronary artery disease before and six month after coronary angioplasty followed by stent implantation.
V. Rudzite, E. Jurika, D. Fuchs, U. Kalnins, A. Erglis, K. Trusinskis.
Importance of the acute coronary syndrome register for the improvement of cardiac care in Latvia.
A.Erglis, I. Zakke, A. Maca, A. Kalvelis, K. Trusinskis, S. Jegere, I. Narbute.
Seminars in Cardiology 2006; 12(1): 8–13.
Intravascular Ultrasound Data and Results of Serum Biochemical Indices at tha Time of Stenting and after Six months in Patients with Coronary Artery Disease.
Acute Coronary Syndrome: Guidelines of Latvian Society of Cardiology.
Secondary risk factors in the progression of coronary artery disease.
Proceedings of the 5th International Congress on Coronary Artery Disease (Frontiers in Coronary Artery Disease), B.S.Lewis, D.A.Halon, M.Y. Flugelman, G.F.Gensini eds., Bologna (Italy), Monduzzi editore, 2003; 175–178.
Simultaneous study of intravascular ultrasound data and results of serum biochemical indices at the time of stenting and after 6 month in patients with coronary artery disease.
Abstr. 2nd Baltic Cardiology Congress 2006, 28–30 September, Riga, Latvia. Seminars in Cardiology, 2006; 12(4): 190.
Unrotected left main PCI registry. Experience of Latvian Centre of Cardiology.
Erglis A, Narbute I, Jegere S, Kumsars I, Dombrovskis A, Lismanis A, Trusinskis K, Mintale I, Zakke I, Strazdins U, Saltups A.
Trends ir the management of acute coronary syndromes in Latvia from 2001 to 2006.
Abstr. ESC Congress 2007. September 1–5, 2007, Vienna, Austria. Eur Heart J 2007; 28(suppl 1): 656–657.
C-Reactive Protein, Neopterin and Homocystein in the progression of coronary heart diseases.
XIX Nordic Congress of Cardiology, Odence, Denmark, June 4–6, 2003. Abstract Book 72; P 74.
V.Rudzite, E.Jurika, D.Fuchs, U.Kalnins, A.Erglis, K.Trusinskis.
Atherosclerosis Supplements 2004; 5: 38–39.
Do we need debulking prior to LM stenting? The Latvian experience.
Erglis A, Kumsars I, Narbute I, Jegere S, Dombrovskis A, Lismanis A, Trusinskis K, Sondore D, Mintale I, Zakke.
Erglis A, Narbute I, Kumsars I, Jegere S, Sondore D, Trusinskis K.
K. Trusinskis, K. Strenge, D. Sondore, I. Narbute, S. Jegere, M. Zabunova, Z. Stelbauma, A. Grave. A.Erglis.
Virtual histology in carotid arteries.
K. Trusinskis, K. Strenge, L. Glazere, D. Sondore, I. Narbute, S. Jegere, M. Zabunova, Z. Stelbauma, A. Grave. A.Erglis.
Cardiology, Int J of Cardiovasc Medicine, Surgery, Pathology and Pharmacology: Abstracts and Program, XXII Nordic- Baltic Congress of VCardiology, Reykjavik, Iceland, June 2009; P039,81.p,134p.
Erglis A, Jegere S, Trusinskis K, Kumsars I, Sondore D, Narbute I. Stent Endothelization after Paclitaxel Eluting Stent Implantation in Left Main: A 3 Years Intravascular Ultrasound and Optical Coherence Tomography Follow-up. Abstr. 21st Transcatheter Cardiovascular Therapeutics Symposium 2009. September 21–25, 2009, San Francisco, USA. Am J Cardiol. 2009; 104(6), suppl 6A: 13D.
Jensen LO, Jegere S, Kumsars I, Narbute I, Sondore D, Trusinskis K, Lassen JF, Thuesen L, Erglis A. Intravascular Ultrasound Assessment of Crush versus Culotte Coronary Bifurcation Stenting Technique. A substudy from the Nordic Stent Technique Study. Abstr. 21st Transcatheter Cardiovascular Therapeutics Symposium 2009. September 21–25, 2009, San Francisco, USA. Am J Cardiol. 2009; 104(6), suppl 6A: 39D-40D.
Trusinskis K, Strenge K, Sondore D, Juhnevica D, Kumsars I, Narbute I, Jegere S, Grave A, Stelbauma Z, Erglis A. Correlation between Tissue Characterization and Biochemical Markers in Acute Coronary Syndrome Patients. XXVI Interventional Cardiology Symposium., Snowmass (Colorado, USA) March, 2010.

References: V. 

V. 

V. 
 V. 

V. 

V. 

V.